TheraNova LLC.

TheraNova pursues a rapid, highly capital-efficient process incorporating all the needed elements of medical device development in a shared services model. TheraNova’s in-house engineering staff and network of specialists and suppliers have the expertise required for every step of the medical device development process. TheraNova and its spinouts have also worked closely with leading reimbursement consultants in the industry and have conducted clinical research in the United States, Europe, and South America. TheraNova has created and spun-out a number of privately funded companies, including:. Theranova’s portfolio of incubated companies is supported by a mix of internal capital, grant and angel funding. Theranova is continuously seeking to recruit the best bio-engineering talent to join our dynamic team. Since its inception in 2005, TheraNova has been able to generate clinical data within a year of funding and with less than $1MM in financing. Burnett has raised, or helped raise, over $250 MM for the fourteen TheraNova spinouts.